Internal control deficiency
An internal control deficiency is a shortcoming in the design or operation of controls as a result of which misstatements or events that threaten objectives are not prevented or detected in a timely manner. For financial reporting, PCAOB AS 2201 grades severity from deficiency through significant deficiency to material weakness. The Dutch Corporate Governance Code 2025 asks for major deficiencies to be reported but does not define the term.
Source: PCAOB AS 2201, paragraphs 78 and 80 and A3, A7 and A11; SEC, 17 CFR 240.12b-2; COSO Internal Control: Integrated Framework (2013), principle 17; Dutch Corporate Governance Code 2025, best practice provisions 1.4.2 and 1.4.3
PCAOB AS 2201 gives a precise definition, for internal control over financial reporting. A deficiency exists when the design or operation of a control does not allow management or employees, in the normal course of their work, to prevent or detect misstatements in a timely manner. In a design deficiency a necessary control is missing or not properly designed; in an operating deficiency a properly designed control does not operate as designed, or the performer lacks the necessary authority or competence (A3). A significant deficiency is less severe than a material weakness, yet important enough to merit the attention of those responsible for oversight of financial reporting (A11). The SEC uses the same definitions of material weakness and significant deficiency (17 CFR 240.12b-2). The auditor communicates material weaknesses in writing to management and the audit committee, and significant deficiencies to the audit committee (paragraphs 78 and 80). SOx 404 applies only to SEC registrants.
COSO Internal Control: Integrated Framework (2013) covers all objectives. Principle 17 requires deficiencies to be evaluated and communicated in a timely manner to those responsible for corrective action, including senior management and the board. Where a major deficiency exists in the presence or functioning of a component or principle, the organisation cannot conclude that its system is effective.
At listed companies, best practice provision 1.4.2 under iv of the Dutch Corporate Governance Code 2025 requires the management board to report the major deficiencies identified during the financial year, with significant changes and planned improvements, discussed with the audit committee and the supervisory board. In the Statement on Risk Management (Verklaring omtrent Risicobeheersing, VOR) it states that the report provides sufficient insight into deficiencies in operation (1.4.3 under i). As the Code does not define the term, the management board itself determines what it regards as a major deficiency; the COSO yardstick fits the framework that the notes to 1.4.2 give as an example.
Last updated: · Editor: ONE Risk Advisory
Frequently asked questions
What is the difference between a deficiency, a significant deficiency and a material weakness?
Under PCAOB AS 2201, a deficiency exists when a control does not prevent or detect misstatements in a timely manner. A material weakness is a deficiency or combination of deficiencies with a reasonable possibility that a material misstatement of the annual or interim financial statements will not be prevented or detected in time. A significant deficiency lies in between: less severe, but important enough to merit the audit committee's attention.
Which deficiencies does the management board report in the management report?
Best practice provision 1.4.2 under iv of the Dutch Corporate Governance Code 2025 asks for the major deficiencies in the internal Risk Management and control systems identified during the financial year, with significant changes and planned improvements. The Code does not define major; the management board therefore determines which yardstick it applies, for example the COSO major deficiency, and can explain it in the management report. The Code applies on a comply or explain basis.